Human serum albumin fragment
CA 1341298 C · Owner: Ballance, David James · Inventors: Hinchliffe, Edward; Ballance, David James; Geisow, Michael John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Polypeptides corresponding to mature human serum albumin residues 1 to n, where n is between 369 and 419 inclusive are useful as substitutes for albumin in the treatment of burns and shock in humans, the clearance of undesirable compounds, (such as bilirubin) from human blood in, laboratory growth media and in HSA assays. HSA (1-387) is particularly preferred although not, novel per se. The polypeptides may be produced by recombinant DNA techniques, especially in yeast.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 25, 2001. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 25, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.